PAPI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 40.463
AS - Asia 23.832
EU - Europa 12.582
SA - Sud America 4.270
AF - Africa 626
OC - Oceania 183
Continente sconosciuto - Info sul continente non disponibili 24
Totale 81.980
Nazione #
US - Stati Uniti d'America 39.650
SG - Singapore 9.068
CN - Cina 5.169
BR - Brasile 3.271
VN - Vietnam 2.701
IT - Italia 2.459
HK - Hong Kong 2.352
DE - Germania 1.894
UA - Ucraina 1.885
FI - Finlandia 1.325
GB - Regno Unito 1.221
TR - Turchia 1.185
FR - Francia 850
JP - Giappone 728
NL - Olanda 723
RU - Federazione Russa 643
SE - Svezia 539
IN - India 535
ID - Indonesia 521
MX - Messico 390
AR - Argentina 370
BD - Bangladesh 313
CA - Canada 299
PL - Polonia 284
IQ - Iraq 195
ZA - Sudafrica 184
AU - Australia 161
EC - Ecuador 155
PK - Pakistan 153
ES - Italia 134
CO - Colombia 129
AT - Austria 122
PH - Filippine 117
MA - Marocco 94
VE - Venezuela 88
MY - Malesia 86
SA - Arabia Saudita 85
PY - Paraguay 83
BE - Belgio 77
UZ - Uzbekistan 76
KR - Corea 74
LT - Lituania 69
TN - Tunisia 66
CL - Cile 65
EG - Egitto 65
TW - Taiwan 64
AE - Emirati Arabi Uniti 62
KE - Kenya 59
PE - Perù 51
CZ - Repubblica Ceca 50
TH - Thailandia 42
DZ - Algeria 41
IE - Irlanda 38
CH - Svizzera 36
UY - Uruguay 31
JO - Giordania 30
NP - Nepal 30
KZ - Kazakistan 28
LB - Libano 26
PT - Portogallo 26
AL - Albania 25
RO - Romania 25
AZ - Azerbaigian 24
BO - Bolivia 22
IL - Israele 22
GR - Grecia 21
IR - Iran 21
NZ - Nuova Zelanda 20
ET - Etiopia 19
JM - Giamaica 18
PS - Palestinian Territory 18
HR - Croazia 16
DO - Repubblica Dominicana 15
RS - Serbia 15
BG - Bulgaria 14
CR - Costa Rica 14
EU - Europa 13
GE - Georgia 12
HN - Honduras 12
NG - Nigeria 12
PA - Panama 12
BH - Bahrain 11
MK - Macedonia 11
OM - Oman 11
GT - Guatemala 10
HU - Ungheria 10
SN - Senegal 10
SY - Repubblica araba siriana 10
NI - Nicaragua 9
SI - Slovenia 9
XK - ???statistics.table.value.countryCode.XK??? 9
DK - Danimarca 8
KH - Cambogia 8
MD - Moldavia 8
VI - Stati Uniti Isole Vergini 8
AO - Angola 7
BY - Bielorussia 7
CY - Cipro 7
LK - Sri Lanka 7
MN - Mongolia 7
Totale 81.804
Città #
Singapore 5.587
Ashburn 4.802
Fairfield 4.048
Woodbridge 3.629
Houston 2.639
Hong Kong 2.307
Jacksonville 2.041
San Jose 1.913
Chandler 1.631
Santa Clara 1.624
Seattle 1.529
Wilmington 1.435
Ann Arbor 1.327
Cambridge 1.319
Beijing 1.313
Dallas 1.263
Ho Chi Minh City 887
Helsinki 732
Izmir 702
Tokyo 688
Nanjing 639
Hanoi 630
Los Angeles 581
Council Bluffs 568
Princeton 564
Lauterbourg 549
Munich 520
New York 399
Jakarta 374
San Diego 371
Ferrara 346
Milan 337
Boardman 313
São Paulo 277
Warsaw 247
Mexico City 245
Chicago 241
Washington 240
Shanghai 217
Nanchang 195
Tianjin 178
Shenyang 173
London 158
Hefei 154
Frankfurt am Main 142
Moscow 142
Buffalo 136
Addison 131
Da Nang 130
Hebei 124
Orem 123
Rome 117
Lappeenranta 116
Changsha 115
Dearborn 109
Nuremberg 108
Haiphong 103
Rio de Janeiro 103
Jiaxing 101
Turku 93
Dong Ket 90
Mountain View 86
Denver 84
Guangzhou 84
Toronto 83
Brooklyn 80
Chennai 80
Falls Church 79
Montreal 79
Baghdad 78
The Dalles 78
Falkenstein 76
Bologna 75
Redwood City 74
Atlanta 72
Zhengzhou 70
Boston 68
Norwalk 66
Tashkent 66
Belo Horizonte 65
Johannesburg 65
Stockholm 61
Vienna 61
Amsterdam 60
Curitiba 60
Manchester 57
Mumbai 55
Quito 55
Jinan 54
Dhaka 53
Kunming 52
Phoenix 51
Sydney 51
Biên Hòa 50
Brussels 50
Bremen 49
Ningbo 48
San Francisco 48
Lahore 47
Naples 46
Totale 54.431
Nome #
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 675
Asthma 491
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 445
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 427
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 337
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 334
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial 317
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 304
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 301
Targeting Th2 cells in asthmatic airways 296
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 274
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 260
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial 257
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD 255
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 251
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 249
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 249
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial 249
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 247
Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion 244
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 244
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules 241
Emphysema contribution to the progression of chronic obstructive pulmonary disease. 236
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 234
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 233
Oxygen radical scavengers inhibit clastogenic activity induced by sonication of human serum 231
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 230
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 224
Bronchopulmonary inflammation and airway smooth muscle hyperresponsiveness induced by nitrogen dioxide in guinea pigs 224
Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A GOLD Science Committee 2022 Review 219
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 216
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma 216
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 216
A serum proteome signature to predict mortality in severe COVID-19 patients 213
Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies 213
Effect of subchronic in vivo exposure to nitrogen dioxide on lung tissue inflammation, airway microvascular leakage, and in vitro bronchial muscle responsiveness in rats 212
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 211
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS) 211
Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma 210
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 209
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 209
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 208
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 208
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial 207
Malattie polmonari primitive da cause dismetaboliche. 205
Diffuse pulmonary meningothelial like nodules simulating metastatic thymoma 205
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline 205
Activation of NF-kappaB transcription factor in asthma death 203
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial 203
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 203
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 199
COPD: early diagnosis and treatment to slow disease progression 199
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 199
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 199
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 199
Enfisema polmonare: prospettive di terapia 198
A new combination therapy for asthma: bridging the gap between effectiveness in trials and clinical practice? 198
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 196
A Novel Insight into Adaptive Immunity in Chronic Obstructive Pulmonary Disease B Cell Activating Factor Belonging to the Tumor Necrosis Factor Family 196
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial 196
Cellule staminali e patologia polmonare dell’adulto 195
A defective type 1 response to rhinovirus in atopic asthma 195
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes 194
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 193
Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations 193
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 193
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial 193
Apporto esogeno di riducenti e attività del rinovirus HRV16 190
Models of infection and exacerbations in COPD. 189
Asthma management 189
A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler 189
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 189
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 188
Rhinovirus vaccination: the case against 187
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 187
A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma 186
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease 185
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 183
Severe Pneumonia following intravescical BCG therapy in a patient with bladder cancer. 183
Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study 183
Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells 182
Management of bronchial asthma 182
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 182
COPD exacerbations: definitions and classifications 182
Association between markers of emphysema and more severe chronic obstructive pulmonary disease 182
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 182
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease 181
Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: A pooled analysis 180
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 180
Mechanisms of rhinovirus-induced asthma 180
Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease 179
Helicobacter pylori and chronic bronchitis 179
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 179
Xanthine oxidase activation by HRV16 infection in respiratory epithelial cells 178
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 177
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation 177
B Cell Activating Factor (BAFF) Is Expressed by Lymphoid Follicles of COPD Patients 176
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells 176
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 176
Tubercolosi extrapolmonare a carico dell’apparato genitale femminile con reazione a catena polimerasica negativa per micobatterio tubercolare. 175
Totale 22.309
Categoria #
all - tutte 374.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 17.148
Totale 391.775


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.324 0 0 0 0 0 0 0 0 0 784 881 659
2021/20225.146 219 452 320 258 197 236 283 293 204 380 461 1.843
2022/20234.213 575 103 145 491 619 645 179 385 531 65 314 161
2023/20242.742 248 267 113 83 137 279 78 136 88 259 348 706
2024/202511.287 303 293 998 331 1.307 813 351 716 1.934 1.653 1.447 1.141
2025/202633.201 2.708 1.677 3.921 4.392 4.676 2.199 4.067 2.238 3.792 3.531 0 0
Totale 83.279